Showing results (231-240 of 463) with videos related to

Sort By:
Pageof 47
Journal of Clinical Psychopharmacology|October 18, 2023
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case SeriesAndrie C Westerkamp, Rob Rodrigues Pereira, Vera R Huitema, et al.
Clinical Pharmacokinetics|January 5, 2017
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population ApproachFranc Andreu, Helena Colom, Laure Elens, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 26, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam StudyM Teichert, L E Visser, R H N van Schaik, et al.
Journal of Neurology|August 11, 2012
FabryScan: a screening tool for early detection of Fabry diseaseKathrin Arning, Dennis Naleschinski, Rainer Maag, et al.
Therapeutic Drug Monitoring|April 28, 2016
Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic SyndromeNynke Teeninga, Zheng Guan, Jasper Stevens, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimusDennis A Hesselink, Ron H N van Schaik, Ilse P van der Heiden, et al.
European Journal of Clinical Pharmacology|June 24, 2011
The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantationSaskia N de Wildt, Ron H N van Schaik, Offie P Soldin, et al.
Journal of the Peripheral Nervous System : JPNS|April 12, 2019
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathyGwen G A van Lieverloo, Luuk Wieske, Camiel Verhamme, et al.
Pageof 47